Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells.

Search TravelDoctorOnline

Authors: Zhou J,Hu SE,Tan SH,Cao R,Chen Y,Xia D,Zhu X,Yang XF,Ong CN,Shen HM,
Address: Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
Journal: Autophagy.


Publication: 2012 Mar;8(3):338-49. doi: 10.4161/auto.18721. Epub 2012 Feb 3.

abstract

suppression of autophagy has been increasingly recognized as a novel cancer therapeutic approach. Andrographolide (Andro), a diterpenoid lactone isolated from an herbal plant Andrographis paniculata, is known to possess anti-inflammatory and anticancer activity. In this study, we sought to examine the effect of Andro on autophagy, and to evaluate whether such effect is relevant to the sensitization effect of Andro on apoptosis induced by DNA damage agents in cancer cells. First, we found that Andro is able to significantly enhance autophagic markers in various cancer cell lines, including GFP-LC3 puncta and LC3-II level. Interestingly, Andro treatment also led to marked increase of p62 protein level and addition of chloroquine (CQ) failed to further enhance either LC3-II or p62 level, indicating that Andro is likely to suppress autophagic flux at the maturation and degradation stage. Next, we provided evidence that Andro inhibits autophagosome maturation not by affecting the lysosomal function, but by impairing autophagosome-lysosome fusion. Lastly, we demonstrated that treatment with cisplatin, a DNA damage agent, induces autophagy in cancer cells. Importantly, Andro is capable of sensitizing cisplatin-induced cell killing determined with both short-term apoptosis assays and long-term clonogenic test, via suppression of autophagy, a process independent of p53. In summary, these observations collectively suggest that Andro could be a promising anti-cancer agent in combination therapy via its potent inhibitory effect on autophagy by disrupting autophagosome-lysosome fusion.



Related Articles
Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation.
Mol Cancer Ther. 2008
Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation.
Zhou J, Lu GD, Ong CS, Ong CN, Shen HM. Mol Cancer Ther. 2008 Jul; 7(7):2170-80.
Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin.
Biochem Pharmacol. 2010
Inhibition of the JAK-STAT3 pathway by andrographolide enhances chemosensitivity of cancer cells to doxorubicin.
Zhou J, Ong CN, Hur GM, Shen HM. Biochem Pharmacol. 2010 May 1; 79(9):1242-50. Epub 2009 Dec 21.
Andrographolide induces autophagic cell death in human liver cancer cells through cyclophilin D-mediated mitochondrial permeability transition pore.
Carcinogenesis. 2012
Andrographolide induces autophagic cell death in human liver cancer cells through cyclophilin D-mediated mitochondrial permeability transition pore.
Chen W, Feng L, Nie H, Zheng X. Carcinogenesis. 2012 Nov; 33(11):2190-8. Epub 2012 Aug 6.
Review Autophagosome formation and molecular mechanism of autophagy.
Antioxid Redox Signal. 2011
Review Autophagosome formation and molecular mechanism of autophagy.
Tanida I. Antioxid Redox Signal. 2011 Jun; 14(11):2201-14. Epub 2010 Dec 4.
Review Chloroquine in cancer therapy: a double-edged sword of autophagy.
Cancer Res. 2013
Review Chloroquine in cancer therapy: a double-edged sword of autophagy.
Kimura T, Takabatake Y, Takahashi A, Isaka Y. Cancer Res. 2013 Jan 1; 73(1):3-7.
Cytotoxic Activity and Apoptosis-Inducing Potential of Di-spiropyrrolidino and Di-spiropyrrolizidino Oxindole Andrographolide Derivatives.
PLoS One. 2013
Cytotoxic Activity and Apoptosis-Inducing Potential of Di-spiropyrrolidino and Di-spiropyrrolizidino Oxindole Andrographolide Derivatives.
Dey SK, Bose D, Hazra A, Naskar S, Nandy A, Munda RN, Das S, Chatterjee N, Mondal NB, Banerjee S, et al. PLoS One. 2013; 8(3):e58055. Epub 2013 Mar 5.
(-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization.
PLoS One. 2012
(-)-Epigallocatechin-3-gallate induces non-apoptotic cell death in human cancer cells via ROS-mediated lysosomal membrane permeabilization.
Zhang Y, Yang ND, Zhou F, Shen T, Duan T, Zhou J, Shi Y, Zhu XQ, Shen HM. PLoS One. 2012; 7(10):e46749. Epub 2012 Oct 8.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.